标题/作者	年份
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic A Gasmi, S Noor, T Tippairote, M Dadar, A Menzel, G Bjørklund Clinical immunology 215, 108409	2020
Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease RS Joshi, SS Jagdale, SB Bansode, SS Shankar, MB Tellis, VK Pandya, ... Journal of Biomolecular Structure and Dynamics 39 (9), 3099-3114	2021
Antivirals for COVID-19: A critical review A Frediansyah, R Tiwari, K Sharun, K Dhama, H Harapan Clinical Epidemiology and global health 9, 90-98	2021
RNA-dependent RNA polymerase as a target for COVID-19 drug discovery W Zhu, CZ Chen, K Gorshkov, M Xu, DC Lo, W Zheng SLAS DISCOVERY: Advancing the Science of Drug Discovery 25 (10), 1141-1151	2020
The journey of remdesivir: from Ebola to COVID-19 J Pardo, AM Shukla, G Chamarthi, A Gupte Drugs in context 9	2020
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies GM Nitulescu, H Paunescu, SA Moschos, D Petrakis, G Nitulescu, ... International journal of molecular medicine 46 (2), 467-488	2020
Remdesivir in covid-19 RE Ferner, JK Aronson Bmj 369	2020
The SARS-coronavirus infection cycle: a survey of viral membrane proteins, their functional interactions and pathogenesis NA Wong, MH Saier Jr International journal of molecular sciences 22 (3), 1308	2021
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis A Rezagholizadeh, S Khiali, P Sarbakhsh, T Entezari-Maleki European journal of pharmacology 897, 173926	2021
Development of remdesivir as a dry powder for inhalation by thin film freezing S Sahakijpijarn, C Moon, JJ Koleng, DJ Christensen, RO Williams Iii Pharmaceutics 12 (11), 1002	2020
Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis A Piscoya, LF Ng-Sueng, A Parra del Riego, R Cerna-Viacava, ... PloS one 15 (12), e0243705	2020
COVID-19, cytokines, inflammation, and spices: How are they related? AB Kunnumakkara, V Rana, D Parama, K Banik, S Girisa, S Henamayee, ... Life sciences 284, 119201	2021
An update on antiviral therapy against SARS-CoV-2: how far have we come? O Indari, S Jakhmola, E Manivannan, HC Jha Frontiers in pharmacology 12, 632677	2021
Drug repositioning: new approaches and future prospects for life-debilitating diseases and the COVID-19 pandemic outbreak ZY Low, IA Farouk, SK Lal Viruses 12 (9), 1058	2020
Therapeutic plasma exchange: a potential management strategy for critically ill COVID-19 patients S Tabibi, T Tabibi, RRZ Conic, N Banisaeed, MB Streiff Journal of Intensive Care Medicine 35 (9), 827-835	2020
Fight against novel coronavirus: a perspective of medicinal chemists SA Amin, T Jha European Journal of Medicinal Chemistry 201, 112559	2020
A review on remdesivir: a possible promising agent for the treatment of COVID-19 SMR Hashemian, T Farhadi, AA Velayati Drug design, development and therapy, 3215-3222	2020
Nucleoside analogs and nucleoside precursors as drugs in the fight against SARS-CoV-2 and other coronaviruses N Borbone, G Piccialli, GN Roviello, G Oliviero Molecules 26 (4), 986	2021
An update of anti-viral treatment of COVID-19. S ŞİMŞEK YAVUZ, İ KOMŞUOĞLU ÇELİKYURT Turkish journal of medical sciences 51	2021
Repurposing old drugs as antiviral agents for coronaviruses CW Yang, TT Peng, HY Hsu, YZ Lee, SH Wu, WH Lin, YY Ke, TA Hsu, ... Biomedical journal 43 (4), 368-374	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。